Mark Ling

2.5k citations
34 papers · 1.7k indexed · h-index 21

Mark Ling

34 papers receiving 1.6k citations

Peers

Mark Ling
Comparison fields: 5 of 90
  • Dermatology 1.1k
  • Immunology and Allergy 269
  • Immunology 438
  • Epidemiology 684
  • Small Animals 90
Replace Kurt Gebauer with:
Kurt Gebauer Australia
Henri Trau Israel
Graham Colver United Kingdom
Efstratios Vakirlis Greece
Magdalene Dohil United States
Jadwiga Roszkiewicz Poland
A.V. Powles United Kingdom
Davide Pennino Germany
Jirô Arata Japan
Bruce Miller United States
Mark Ling relative to Kurt Gebauer Australia Kurt Gebauer's profile →
Citations per field
00.5×1.6×
Kurt Gebauer · 1×
Citations per year

Countries citing papers authored by Mark Ling

Since Specialization
Citations

This map shows the geographic impact of Mark Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ling more than expected).

Fields of papers citing papers by Mark Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ling. The network helps show where Mark Ling may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Ling Line = papers co-authored together Mark Ling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
201810
2 201155
3 2009101
4
Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
200753
5 200625
6 2005127
7 200529
8 200517
9 2004172
10 200495
11 200328
12
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
200270
13 200282
14 200114
15 2001218
16 2000158
17 199941
18 199810
19 1998106
20 19965

About Mark Ling

Mark Ling is a scholar working on Dermatology, Immunology and Allergy, Immunology, Epidemiology and Oral Surgery, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (8 papers), Acne and Rosacea Treatments and Effects (7 papers), Nonmelanoma Skin Cancer Studies (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Nail Diseases and Treatments (4 papers), Photodynamic Therapy Research Studies (3 papers), Cutaneous Melanoma Detection and Management (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Dermatology (1.1k citations), Immunology and Allergy (269 citations), Immunology (438 citations), Epidemiology (684 citations) and Small Animals (90 citations). Mark Ling has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Debra Breneman, Jon M. Hanifin, Elyse S. Rafal, Richard G. Langley, James H. Lee, Robert Matheson, Mark Lebwohl, Alice B. Gottlieb, Tania J. Phillips and Gerald D. Weinstein. Their work appears in journals such as Journal of the American Academy of Dermatology, Dermatologic Surgery, Journal of Cutaneous Medicine and Surgery, Journal of Dermatological Science and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026